BACKGROUND: The marginal delineation of gliomas cannot be defined by conventional imaging due to their infiltrative growth pattern. Here we investigate the relationship between changes in glioma metabolism by proton magnetic resonance spectroscopic imaging ((1)H-MRSI) and histopathological findings in order to determine an optimal threshold value of choline/N-acetyl-aspartate (Cho/NAA) that can be used to define the extent of glioma spread. METHOD: Eighteen patients with different grades of glioma were examined using (1)H-MRSI. Needle biopsies were performed under the guidance of neuronavigation prior to craniotomy. Intraoperative magnetic resonance imaging (MRI) was performed to evaluate the accuracy of sampling. Haematoxylin and eosin, and immunohistochemical staining with IDH1, MIB-1, p53, CD34 and glial fibrillary acidic protein (GFAP) antibodies were performed on all samples. Logistic regression analysis was used to determine the relationship between Cho/NAA and MIB-1, p53, CD34, and the degree of tumour infiltration. The clinical threshold ratio distinguishing tumour tissue in high-grade (grades III and IV) glioma (HGG) and low-grade (grade II) glioma (LGG) was calculated. RESULTS: In HGG, higher Cho/NAA ratios were associated with a greater probability of higher MIB-1 counts, stronger CD34 expression, and tumour infiltration. Ratio threshold values of 0.5, 1.0, 1.5 and 2.0 appeared to predict the specimens containing the tumour with respective probabilities of 0.38, 0.60, 0.79, 0.90 in HGG and 0.16, 0.39, 0.67, 0.87 in LGG. CONCLUSIONS: HGG and LGG exhibit different spectroscopic patterns. Using (1)H-MRSI to guide the extent of resection has the potential to improve the clinical outcome of glioma surgery.
BACKGROUND: The marginal delineation of gliomas cannot be defined by conventional imaging due to their infiltrative growth pattern. Here we investigate the relationship between changes in glioma metabolism by proton magnetic resonance spectroscopic imaging ((1)H-MRSI) and histopathological findings in order to determine an optimal threshold value of choline/N-acetyl-aspartate (Cho/NAA) that can be used to define the extent of glioma spread. METHOD: Eighteen patients with different grades of glioma were examined using (1)H-MRSI. Needle biopsies were performed under the guidance of neuronavigation prior to craniotomy. Intraoperative magnetic resonance imaging (MRI) was performed to evaluate the accuracy of sampling. Haematoxylin and eosin, and immunohistochemical staining with IDH1, MIB-1, p53, CD34 and glial fibrillary acidic protein (GFAP) antibodies were performed on all samples. Logistic regression analysis was used to determine the relationship between Cho/NAA and MIB-1, p53, CD34, and the degree of tumour infiltration. The clinical threshold ratio distinguishing tumour tissue in high-grade (grades III and IV) glioma (HGG) and low-grade (grade II) glioma (LGG) was calculated. RESULTS: In HGG, higher Cho/NAA ratios were associated with a greater probability of higher MIB-1 counts, stronger CD34 expression, and tumour infiltration. Ratio threshold values of 0.5, 1.0, 1.5 and 2.0 appeared to predict the specimens containing the tumour with respective probabilities of 0.38, 0.60, 0.79, 0.90 in HGG and 0.16, 0.39, 0.67, 0.87 in LGG. CONCLUSIONS: HGG and LGG exhibit different spectroscopic patterns. Using (1)H-MRSI to guide the extent of resection has the potential to improve the clinical outcome of glioma surgery.
Authors: A Narayana; J Chang; S Thakur; W Huang; S Karimi; B Hou; A Kowalski; G Perera; A Holodny; P H Gutin Journal: Br J Radiol Date: 2006-10-26 Impact factor: 3.039
Authors: David Capper; Hanswalter Zentgraf; Jörg Balss; Christian Hartmann; Andreas von Deimling Journal: Acta Neuropathol Date: 2009-10-02 Impact factor: 17.088
Authors: Tracy R McKnight; Kathleen R Lamborn; Tonya D Love; Mitchel S Berger; Susan Chang; William P Dillon; Andrew Bollen; Sarah J Nelson Journal: J Neurosurg Date: 2007-04 Impact factor: 5.115
Authors: Andreas Stadlbauer; Christopher Nimsky; Rolf Buslei; Katja Pinker; Stephan Gruber; Thilo Hammen; Michael Buchfelder; Oliver Ganslandt Journal: Invest Radiol Date: 2007-04 Impact factor: 6.016
Authors: Andreas Stadlbauer; Ewald Moser; Stephan Gruber; Rolf Buslei; Christopher Nimsky; Rudolf Fahlbusch; Oliver Ganslandt Journal: Neuroimage Date: 2004-10 Impact factor: 6.556
Authors: Tejas Sankar; Zografos Caramanos; Rachid Assina; Jean-Guy Villemure; Richard Leblanc; Adrian Langleben; Douglas L Arnold; Mark C Preul Journal: J Neurooncol Date: 2008-07-04 Impact factor: 4.130
Authors: Hamed Akbari; Luke Macyszyn; Xiao Da; Ronald L Wolf; Michel Bilello; Ragini Verma; Donald M O'Rourke; Christos Davatzikos Journal: Radiology Date: 2014-06-19 Impact factor: 11.105
Authors: James S Cordova; Hui-Kuo G Shu; Zhongxing Liang; Saumya S Gurbani; Lee A D Cooper; Chad A Holder; Jeffrey J Olson; Brad Kairdolf; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Hyunsuk Shim Journal: Neuro Oncol Date: 2016-03-15 Impact factor: 12.300
Authors: Jörg Mauler; Andrew A Maudsley; Karl-Josef Langen; Omid Nikoubashman; Gabriele Stoffels; Sulaiman Sheriff; Philipp Lohmann; Christian Filss; Norbert Galldiks; Elena Rota Kops; N Jon Shah Journal: J Nucl Med Date: 2017-08-28 Impact factor: 10.057
Authors: Max-Ludwig Schäfer; Martin H Maurer; Michael Synowitz; Joost Wüstefeld; Tim Marnitz; Florian Streitparth; Edzard Wiener Journal: Eur Radiol Date: 2013-05-19 Impact factor: 5.315